A
Athira Pharma
ATHA
3.26000
USD
0.04
(1.24%)
مغلق
حجم التداول
2,507,510
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
23,367,296
العنوان: Athira Pharma
القطاع: Healthcare
الصناعة: Biotechnology
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 andATH-1019.